Genomic Health today announced the presentation of new data with the Oncotype DX® test at the 11th European Breast Cancer Conference (EBCC-11) in Barcelona, Spain

The presentations underline the substantial real-world evidence available for Oncotype DX and reflect the growing adoption of the test across Europe to personalize and improve the quality of clinical decisions, leading to better patient outcomes and more cost-effective treatment.

Access to the full press release

Find an actor

Swiss eHealth Summit 201811.09.2018

L'événement se déroulera le 11 et 12 septembre 2018 au Stade de Suisse à Berne, sous le thème "Leadership &...

Joint the "Data & Electronics Business Mission", Silicon Valley / CES 2019 Januray 6-12, 2019

Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn